Superior Glycation Finish Merchandise Are Related With Diabetic Macular Edema
This was a cross-sectional examine was carried out within the Hacettepe College Hospital, Division of Ophthalmology, between July 2018 and February 2019.
Whereas benefiting from the outcomes of the earlier research, the pattern measurement of the analysis was kind 1 error stage α = 0.05 and sort 2 stage β = 0.20.
The facility evaluation was statistically calculated utilizing NCCS PAS 11 program. The current examine was carried out with 90 sufferers: 50 case-patients (DM with DME) and 40 management sufferers (DM with out DME).
Excluded from the examine had been these below the age of 18 years, with no analysis of Kind 2 DM, with none anti-diabetic agent, with any illness apart from DME and DR which will have an effect on the retina, with any illness which will have an effect on the retina for the management group, with corneal, lens or vitreous opacification stopping Optical coherence tomography (OCT) withdrawal, with any systemic illness apart from DM and hypertension, with a historical past of eye surgical procedure, and with blindness or an infection within the eye, together with these lately recognized with diabetes (<1 yr) and people with particular diets.
pb Peptide |
|||
MBS3233745-01mg | MyBiosource | 0.1mg | EUR 180 |
pb Peptide |
|||
MBS3233745-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
Human PB Plasma |
|||
ABC-TC4012 | AcceGen | 1 vial | Ask for price |
Description: NPB Plasma is obtained from healthy donors through the COBE Spectra apheresis machine. Between 50 and 150mL of autologous plasma is collected at the same time as the mononuclear cells. |
Human PB Neutrophils |
|||
ABC-TC4289 | AcceGen | 40M | Ask for price |
Description: Neutrophils compose between 40-75% of white blood cells in the body. They serve as first responders of the inflammatory response of the immune system. |
Human PB Platelets |
|||
ABC-TC4291 | AcceGen | 1 vial | Ask for price |
Description: Platelets help to stop bleeding at wound sites. When activated, they gather at the site of the wound, change shape and connect to each other to stop the bleeding. |
Human Asthma PB |
|||
ABC-TC4295 | AcceGen | 1 pack | Ask for price |
Description: <div Asthma is a condition that causes airways to swell and narrow. This creates problems with breathing and can result in coughing, wheezing, shortness of breath, extra mucous production. It can result from an allergic reaction and other hypersensitivities.</div<div <div Specimens available from both adults and pediatric donors. Included types: acute, chronic, severe, bronchial, exercise-induced, allergy-induced, controlled, intermittent, intrinsic, epostic.</div</div<br / |
Human Osteoarthritis PB |
|||
ABC-TC4306 | AcceGen | 1 pack | Ask for price |
Description: Osteoarthritis is a degenerative joint disease which causes the loss of cartilage, eventually progressing to development of painful bony spurs and cysts in the joints that are affected. |
Human Sjogren's PB |
|||
ABC-TC4314 | AcceGen | 1 pack | Ask for price |
Description: Sjogrenand#39;s (SHOW-grins) syndrome is a disorder of your immune system identified by its two most common symptoms - dry eyes and a dry mouth. Sjogrenand#39;s syndrome often accompanies other immune system disorders, such as rheumatoid arthritis and lupus. |
Human Scleroderma PB |
|||
ABC-TC4317 | AcceGen | 1 pack | Ask for price |
Description: Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues - the fibers that provide the framework and support for your body. |
Human COPD PB |
|||
ABC-TC4318 | AcceGen | 1 pack | Ask for price |
Description: Clinical data may include: Medication (current and historical), Disease Severity, Smoking History, GOLD Stage, Spirometry, Lung function test (FEV, FVC, FEV1%), standard blood chemistry results |
Human PB Leukocytes |
|||
ABC-TC4380 | AcceGen | 1 vial | Ask for price |
Description: Human Peripheral Blood Leukocyte Primary Cell was derived from Human Peripheral Blood. Cells are positive for CD309, CD19, CD5, CD7, CD9, CD15, CD22, CD45a, CD45 and CD47. |
MC Cellufine PB |
|||
202-15 | JNC America | 1 x 5 ml | EUR 542.4 |
MC Cellufine PB |
|||
202-51 | JNC America | 5 x 1 ml | EUR 542.4 |
PB Blocking Peptide |
|||
33R-2067 | Fitzgerald | 100 ug | EUR 119 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192 |
PB Cadherin Antibody |
|||
47938 | SAB | 100ul | EUR 319 |
PB Cadherin Antibody |
|||
47938-100ul | SAB | 100ul | EUR 302.4 |
PB Cadherin Antibody |
|||
E047938 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
PB 28 dihydrochloride |
|||
B7107-10 | ApexBio | 10 mg | EUR 187 |
Description: A mixed σ2 receptor agonist/σ1 receptor antagonist |
PB 28 dihydrochloride |
|||
B7107-50 | ApexBio | 50 mg | EUR 780 |
Description: A mixed σ2 receptor agonist/σ1 receptor antagonist |
PB succiniMidyl ester |
|||
T39632-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-1g | TargetMol Chemicals | 1g | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: PB succiniMidyl ester |
PB Buffer (powder) |
|||
HTCC05-2L | Shanghai WSHT Biotechnology | 2L | EUR 7.2 |
5F-PB-22 |
|||
F595165 | Toronto Research Chemicals | 100mg | EUR 3000 |
Description: 1400742-41-7 |
PB 28 dihydrochloride |
|||
B7107-1 | ApexBio | 1mg | EUR 40 |
Description: GPCR/G protein|Sigma Receptor |
PB 28 dihydrochloride |
|||
B7107-25 | ApexBio | 25mg | EUR 296 |
Description: GPCR/G protein|Sigma Receptor |
PB 28 dihydrochloride |
|||
B7107-5 | ApexBio | 5mg | EUR 128 |
Description: GPCR/G protein|Sigma Receptor |
PB succiniMidyl ester |
|||
MBS5800073-5mg | MyBiosource | 5(mg | EUR 915 |
PB succiniMidyl ester |
|||
MBS5800073-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
PB 28 dihydrochloride |
|||
MBS5757591-25mg | MyBiosource | 25mg | EUR 1030 |
PB 28 dihydrochloride |
|||
MBS5757591-5x25mg | MyBiosource | 5x25mg | EUR 4490 |
PB Cadherin Antibody |
|||
MBS9430919-01mL | MyBiosource | 0.1mL | EUR 305 |
PB Cadherin Antibody |
|||
MBS9430919-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
pB-dCas9-PBE |
|||
PVT29660 | Nova Lifetech | 2ug | EUR 280 |
PB succiniMidyl ester |
|||
HY-133532 | MedChemExpress | 5mg | EUR 989.19 |
Description: PB succiniMidyl ester (Ocean Blue, SE) is a fluorophore with the λexcitation/emission of ~405/455 nm[1]. |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (AP) |
|||
MBS6447020-01mL | MyBiosource | 0.1mL | EUR 950 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (AP) |
|||
MBS6447020-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (PE) |
|||
MBS6447030-01mL | MyBiosource | 0.1mL | EUR 950 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (PE) |
|||
MBS6447030-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) |
|||
MBS6002900-02mL | MyBiosource | 0.2(mL | EUR 695 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) |
|||
MBS6002900-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (APC) |
|||
MBS6447021-01mL | MyBiosource | 0.1mL | EUR 950 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (APC) |
|||
MBS6447021-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (FITC) |
|||
MBS6447023-01mL | MyBiosource | 0.1mL | EUR 950 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (FITC) |
|||
MBS6447023-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (HRP). |
|||
MBS6447024-01mL | MyBiosource | 0.1mL | EUR 950 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (HRP). |
|||
MBS6447024-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) |
|||
MBS649366-02mL | MyBiosource | 0.2mL | EUR 695 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) |
|||
MBS649366-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (AP) |
|||
MBS6305449-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (AP) |
|||
MBS6305449-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (PE) |
|||
MBS6305459-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (PE) |
|||
MBS6305459-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (AP) |
|||
MBS6305460-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (AP) |
|||
MBS6305460-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (PE) |
|||
MBS6305470-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (PE) |
|||
MBS6305470-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) |
|||
MBS6006567-02mL | MyBiosource | 0.2(mL | EUR 695 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) |
|||
MBS6006567-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (Biotin) |
|||
MBS6447022-01mL | MyBiosource | 0.1mL | EUR 950 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (Biotin) |
|||
MBS6447022-5x01mL | MyBiosource | 5x0.1mL | EUR 4120 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) (AP) |
|||
MBS6305438-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) (AP) |
|||
MBS6305438-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) (APC) |
|||
MBS6305439-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) (APC) |
|||
MBS6305439-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) (PE) |
|||
MBS6305448-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS1, ID (HAS1, HAS, Hyaluronan synthase 1, Hyaluronate synthase 1, Hyaluronic acid synthase 1) (PE) |
|||
MBS6305448-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (APC) |
|||
MBS6305450-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (APC) |
|||
MBS6305450-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (FITC) |
|||
MBS6305452-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS2, ID (HAS2, Hyaluronan synthase 2, Hyaluronate synthase 2, Hyaluronic acid synthase 2) (FITC) |
|||
MBS6305452-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (APC) |
|||
MBS6305461-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (APC) |
|||
MBS6305461-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (FITC) |
|||
MBS6305463-02mL | MyBiosource | 0.2mL | EUR 980 |
HAS3, ID (HAS3, Hyaluronan synthase 3, Hyaluronate synthase 3, Hyaluronic acid synthase 3) (FITC) |
|||
MBS6305463-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
Nori® Hyaluronan (Hyaluronic Acid) ELISA Kit |
|||
GR217003 | Genorise Scientific | 96-well | EUR 461 |
HAS3 (Hyaluronan Synthase 3, Hyaluronate Synthase 3, Hyaluronic Acid Synthase 3) (MaxLight 405) |
|||
MBS6447025-01mL | MyBiosource | 0.1mL | EUR 950 |
This the examine was carried out in accordance with the Declaration of Helsinki Moral Rules.
OCT withdrawals and CFT evaluations of these included within the examine had been made by the physician and directed to the dietician (researcher).
Demographic knowledge and the dietary habits had been collected by standardized face-to-face interviewer-assisted questionnaires.
The body weight and top of sufferers had been measured utilizing a calibrated physique composition analyser and weight scales by researcher.
BMI was evaluated based mostly on the WHO classification. Waist and hip circumference was additionally measured and evaluated when it comes to excessive threat of growing continual illnesses.
Speculation: If the waist/hip ratio is ≥0.85 for ladies and ≥0.90 for males, the danger of growing continual illnesses will increase.
Diabetic macular edema (DME) Examination After an in depth systemic and ophthalmological historical past was taken from all topics by the physician, the best-corrected visible acuity stage was measured utilizing an ETDRS chart.
A fundus examination was carried out with a 90 D lens after anterior phase examination and pupil dilation with a biomicroscope.
A spectral-domain OCT (Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany) was utilized for the analysis of CFT.
After a minimal of eight hours of fasting, roughly 5 ml of peripheral venous blood was collected from the antecubital area within the HÜTF Ophthalmology Clinic between 08:00 and 10:00.
Evaluation of dietary consumption and dietary AGEs The dietary consumption of contributors was assessed utilizing a validated quantitative meals frequency questionnaire (QFFQ) (together with about 110 meals gadgets take 20-25 minutes to finish).
Meals had been categorized into eight classes: dairy merchandise, meat merchandise, fruits, greens, bread and cereals, drinks, and desserts. Additionally, questions had been requested to sufferers about conventional cooking strategies to calculate dietary AGE intakes.
Corresponding to what cooking strategies do they cook dinner the meals? How lengthy do they cook dinner the meals?
Standardized meals recipes for Turkey and the Vitamin Data System (BEBIS) program had been used to calculate the common each day vitality and nutrient consumption for every participant.
In the meantime, to evaluate dietary AGEs from the QFFQ, every meals’s contribution to dAGEs consumption was calculated based mostly on the Advance Glycation Finish Merchandise in Meals Desk printed by the Uribarri et al., which includes knowledge on 549fooditems.
Pattern Assortment and Evaluation The serum samples collected in the course of the analysis had been delivered to the laboratory whereas preserving the chilly chain. The enzyme-labeled immune “Enzyme-Linked Immunosorbent Assay (ELISA)” check was carried out with biologists of the corporate utilizing a Biotek 800TS gadget.
Whereas analyzing the samples, Human CML Elisa Package 96 checks for serum AGE and Human RAGE Elisa Package 96 check kits for serum RAGE had been used. Carboxymethyl lysine (CML) was thought of because the AGE parameter, being probably the most simply detected and probably the most plentiful kind of AGE in people.
The minimumdetectable dose of CML in people is usually lower than 15.6 pg/ml
PB antibody |
|||
MBS839577-01mL | MyBiosource | 0.1mL | EUR 750 |
PB antibody |
|||
MBS839577-5x01mL | MyBiosource | 5x0.1mL | EUR 3215 |
pb Peptide |
|||
MBS3233745-01mg | MyBiosource | 0.1mg | EUR 180 |
pb Peptide |
|||
MBS3233745-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
Human PB Plasma |
|||
ABC-TC4012 | AcceGen | 1 vial | Ask for price |
Description: NPB Plasma is obtained from healthy donors through the COBE Spectra apheresis machine. Between 50 and 150mL of autologous plasma is collected at the same time as the mononuclear cells. |
Human PB Neutrophils |
|||
ABC-TC4289 | AcceGen | 40M | Ask for price |
Description: Neutrophils compose between 40-75% of white blood cells in the body. They serve as first responders of the inflammatory response of the immune system. |
Human PB Platelets |
|||
ABC-TC4291 | AcceGen | 1 vial | Ask for price |
Description: Platelets help to stop bleeding at wound sites. When activated, they gather at the site of the wound, change shape and connect to each other to stop the bleeding. |
Human Asthma PB |
|||
ABC-TC4295 | AcceGen | 1 pack | Ask for price |
Description: <div Asthma is a condition that causes airways to swell and narrow. This creates problems with breathing and can result in coughing, wheezing, shortness of breath, extra mucous production. It can result from an allergic reaction and other hypersensitivities.</div<div <div Specimens available from both adults and pediatric donors. Included types: acute, chronic, severe, bronchial, exercise-induced, allergy-induced, controlled, intermittent, intrinsic, epostic.</div</div<br / |
Human Osteoarthritis PB |
|||
ABC-TC4306 | AcceGen | 1 pack | Ask for price |
Description: Osteoarthritis is a degenerative joint disease which causes the loss of cartilage, eventually progressing to development of painful bony spurs and cysts in the joints that are affected. |
Human Sjogren's PB |
|||
ABC-TC4314 | AcceGen | 1 pack | Ask for price |
Description: Sjogrenand#39;s (SHOW-grins) syndrome is a disorder of your immune system identified by its two most common symptoms - dry eyes and a dry mouth. Sjogrenand#39;s syndrome often accompanies other immune system disorders, such as rheumatoid arthritis and lupus. |
Human Scleroderma PB |
|||
ABC-TC4317 | AcceGen | 1 pack | Ask for price |
Description: Scleroderma is a group of rare diseases that involve the hardening and tightening of the skin and connective tissues - the fibers that provide the framework and support for your body. |
Human COPD PB |
|||
ABC-TC4318 | AcceGen | 1 pack | Ask for price |
Description: Clinical data may include: Medication (current and historical), Disease Severity, Smoking History, GOLD Stage, Spirometry, Lung function test (FEV, FVC, FEV1%), standard blood chemistry results |
Human PB Leukocytes |
|||
ABC-TC4380 | AcceGen | 1 vial | Ask for price |
Description: Human Peripheral Blood Leukocyte Primary Cell was derived from Human Peripheral Blood. Cells are positive for CD309, CD19, CD5, CD7, CD9, CD15, CD22, CD45a, CD45 and CD47. |
MC Cellufine PB |
|||
202-15 | JNC America | 1 x 5 ml | EUR 542.4 |
MC Cellufine PB |
|||
202-51 | JNC America | 5 x 1 ml | EUR 542.4 |
PB Blocking Peptide |
|||
33R-2067 | Fitzgerald | 100 ug | EUR 119 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of pb antibody, catalog no. 70R-2192 |
PB Cadherin Antibody |
|||
47938 | SAB | 100ul | EUR 319 |
PB Cadherin Antibody |
|||
47938-100ul | SAB | 100ul | EUR 302.4 |
PB Cadherin Antibody |
|||
E047938 | EnoGene | 100μg/100μl | EUR 255 |
Description: Available in various conjugation types. |
PB 28 dihydrochloride |
|||
B7107-10 | ApexBio | 10 mg | EUR 187 |
Description: A mixed σ2 receptor agonist/σ1 receptor antagonist |
PB 28 dihydrochloride |
|||
B7107-50 | ApexBio | 50 mg | EUR 780 |
Description: A mixed σ2 receptor agonist/σ1 receptor antagonist |
PB succiniMidyl ester |
|||
T39632-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-1g | TargetMol Chemicals | 1g | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: PB succiniMidyl ester |
PB succiniMidyl ester |
|||
T39632-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: PB succiniMidyl ester |
PB Buffer (powder) |
|||
HTCC05-2L | Shanghai WSHT Biotechnology | 2L | EUR 7.2 |
5F-PB-22 |
|||
F595165 | Toronto Research Chemicals | 100mg | EUR 3000 |
Description: 1400742-41-7 |
PB 28 dihydrochloride |
|||
B7107-1 | ApexBio | 1mg | EUR 40 |
Description: GPCR/G protein|Sigma Receptor |
PB 28 dihydrochloride |
|||
B7107-25 | ApexBio | 25mg | EUR 296 |
Description: GPCR/G protein|Sigma Receptor |
PB 28 dihydrochloride |
|||
B7107-5 | ApexBio | 5mg | EUR 128 |
Description: GPCR/G protein|Sigma Receptor |
PB succiniMidyl ester |
|||
MBS5800073-5mg | MyBiosource | 5(mg | EUR 915 |
PB succiniMidyl ester |
|||
MBS5800073-5x5mg | MyBiosource | 5x5(mg | EUR 3970 |
PB 28 dihydrochloride |
|||
MBS5757591-25mg | MyBiosource | 25mg | EUR 1030 |
PB 28 dihydrochloride |
|||
MBS5757591-5x25mg | MyBiosource | 5x25mg | EUR 4490 |
PB Cadherin Antibody |
|||
MBS9430919-01mL | MyBiosource | 0.1mL | EUR 305 |
PB Cadherin Antibody |
|||
MBS9430919-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
pB-dCas9-PBE |
|||
PVT29660 | Nova Lifetech | 2ug | EUR 280 |
PB succiniMidyl ester |
|||
HY-133532 | MedChemExpress | 5mg | EUR 989.19 |
Description: PB succiniMidyl ester (Ocean Blue, SE) is a fluorophore with the λexcitation/emission of ~405/455 nm[1]. |
Human MS PB Plasma |
|||
ABC-TC3944 | AcceGen | 1 vial | Ask for price |
Description: Multiple Sclerosis (MS) peripheral blood plasma is obtained by centrifugation of the MS PB. This product has a diminished number of cells and platelets. Fresh MS PB plasma is available upon request. |
Human OA PB Plasma |
|||
ABC-TC4014 | AcceGen | 1 vial | Ask for price |
Description: Osteoarthritis peripheral blood plasma is obtained by centrifugation of the Osteoarthritis PB. This product has a diminished number of cells and platelets. Fresh Osteoarthritis PB plasma is available upon request. |
Porcine PB Mononuclear Cells |
|||
ABC-TC4034 | AcceGen | 1 vial | Ask for price |
Description: Porcine Mononuclear Cells are isolated from fresh blood of a mixed breed of pigs (Yorkshire, Hampshire, Poland China). The mononuclear fraction is then further processed to eliminate red blood cells and platelets. |
Human Psoriasis PB Plasma |
|||
ABC-TC4045 | AcceGen | 1 vial | Ask for price |
Description: Psoriasis peripheral blood plasma is obtained by centrifugation of the Psoriasis PB. This product has a diminished number of cells and platelets. Fresh Psoriasis PB plasma is available upon request. |
Human RA PB Plasma |
|||
ABC-TC4053 | AcceGen | 1 vial | Ask for price |
Description: Rheumatoid Arthritis (RA) peripheral blood plasma is obtained by centrifugation of the RA PB. This product has a diminished number of cells and platelets. Fresh RA PB plasma is available upon request. |
Human SLE PB Plasma |
|||
ABC-TC4255 | AcceGen | 1 vial | Ask for price |
Description: Systemic Lupus Erythematosus (SLE) peripheral blood plasma is obtained by centrifugation of the SLE PB. This product has a diminished number of cells and platelets. Fresh SLE PB plasma is available upon request. |
Human Hepatitis B PB |
|||
ABC-TC4298 | AcceGen | 1 pack | Ask for price |
Description: Hepatitis B is a potentially serious liver disease. The Hepatitis B virus can cause inflammation of the liver, cirrhosis and cancer. Hepatitis B can range from mild to severe. It is one of the most common chronic disease in the world. |
Human Hepatitis C PB |
|||
ABC-TC4300 | AcceGen | 1 pack | Ask for price |
Description: Hepatitis C (HCV) primarily causes a long-lasting liver disease. It is spread by contact with infected blood. It first became evident in 1974 that a non A/non B hepatitis virus existed. Finally, a test was discovered that could be used to identify the virus in 1989 and from the early 1990s all blood units were screened for HCV. Hepatitis C is more likely than Hepatitis B to cause liver disease. |
Human HIV-1 PB |
|||
ABC-TC4302 | AcceGen | 1 pack | Ask for price |
Description: HIV-1 is the most common subtype of the lentivirus HIV which infects T helper cells of the immune system. HIV-1 is found worldwide. |
Human HIV-2 PB |
|||
ABC-TC4304 | AcceGen | 1 pack | Ask for price |
Description: HIV type 2 is a sub species of the lentivirus HIV. HIV-2 has a slower progression rate of the disease, as well as lower rates of transmission compared to HIV-1. Often patients infected with HIV-2 have a low viral load and a slower rate of CD4 cell count decline as compared those infected with HIV-1. |
Human Rheumatoid Arthritis PB |
|||
ABC-TC4308 | AcceGen | 1 pack | Ask for price |
Description: Characteristics of Rheumatoid Arthritis include joint inflammation, but can also include other areas of the body. It is a systemic illness that can also include inflammation in tissues of the heart, lungs and eyes. |
Human Ulcerative Colitis PB |
|||
ABC-TC4313 | AcceGen | 1 pack | Ask for price |
Description: Ulcerative Colitis is an immune disease characterized by ulcer formation and inflammation of the large intestine. |
Human Lyme Disease PB |
|||
ABC-TC4315 | AcceGen | 1 pack | Ask for price |
Description: Lyme disease is caused by four main species of bacteria: Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii bacteria. The most common tick-borne illness in these regions, Lyme disease is transmitted by the bite of an infected black-legged tick, commonly known as a deer tick. |
PB Cadherin Blocking Peptide |
|||
20-abx162098 | Abbexa |
|
|
Anti-PB Cadherin Antibody |
|||
E38A4887 | EnoGene | 100ug/100ul | EUR 225 |
Description: Available in various conjugation types. |
PB Cadherin Conjugated Antibody |
|||
C47938 | SAB | 100ul | EUR 476.4 |
AAP47877-100UG - pb Peptide |
|||
AAP47877-100UG | Aviva Systems Biology | 100ug | EUR 99 |
Pb-chelate ELISA Kit |
|||
ELKFS096 | ELK Biotech | 96Tests | EUR 175 |
PB-cadherin Rabbit pAb |
|||
E2370204 | EnoGene | 100ul | EUR 225 |
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
PB Cadherin Blocking Peptide |
|||
MBS8244206-1mg | MyBiosource | 1mg | EUR 190 |
PB Cadherin Blocking Peptide |
|||
MBS8244206-5mg | MyBiosource | 5mg | EUR 345 |
PB Cadherin Blocking Peptide |
|||
MBS8244206-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
Anti-PB Cadherin Antibody |
|||
MBS8242703-003mL | MyBiosource | 0.03mL | EUR 185 |
Anti-PB Cadherin Antibody |
|||
MBS8242703-01mL | MyBiosource | 0.1mL | EUR 255 |
Anti-PB Cadherin Antibody |
|||
MBS8242703-02mL | MyBiosource | 0.2mL | EUR 335 |
Anti-PB Cadherin Antibody |
|||
MBS8242703-5x02mL | MyBiosource | 5x0.2mL | EUR 1420 |
pb antibody - middle region |
|||
MBS3208782-01mL | MyBiosource | 0.1mL | EUR 455 |
pb antibody - middle region |
|||
MBS3208782-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
PB Cadherin Conjugated Antibody |
|||
MBS9455773-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
PB Cadherin Conjugated Antibody |
|||
MBS9455773-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
PB Cadherin Conjugated Antibody |
|||
MBS9455773-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
PB Cadherin Conjugated Antibody |
|||
MBS9455773-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
PB Cadherin Conjugated Antibody |
|||
MBS9455773-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
Human Crohn's Disease PB Plasma |
|||
ABC-TC3392 | AcceGen | 1 vial | Ask for price |
Description: Crohn's Disease peripheral blood plasma is obtained by centrifugation of the PB. This product has a diminished number of cells and platelets. Fresh Crohn's PB plasma is available upon request. |
Non-human Primate PB Plasma |
|||
ABC-TC3966 | AcceGen | 1 vial | Ask for price |
Description: Non-human primate-Plasma is processed through centrifugation to diminish cells and platelets. |
Human PB CD8+ T Cells |
|||
ABC-TC4005 | AcceGen | 1 vial | Ask for price |
Description: NPB-CD8+ Cytotoxic T cells are negatively isolated from Mononuclear Cells using an indirect immunomagnetic CD8+ T cell labeling system. |
Human PB Pan T Cells |
|||
ABC-TC4011 | AcceGen | 1 vial | Ask for price |
Description: NPB-Pan T Cells are negatively isolated from mononuclear cells using an indirect immunomagnetic Pan-T labeling system. |
Human Ulcerative Colitis PB Plasma |
|||
ABC-TC4268 | AcceGen | 1 vial | Ask for price |
Description: Ulcerative Colitis peripheral blood plasma is obtained by centrifugation of the PB. This product has a diminished number of cells and platelets. Fresh Ulcerative Colitis PB plasma is available upon request. |
Human Type 2 Diabetes PB |
|||
ABC-TC4312 | AcceGen | 1 pack | Ask for price |
Description: Non-RI dependent diabetes, or Type 2 Diabetes, is characterized by hyperglycemia that is caused by a combination of RI resistance and the body's inability to compensate by producing more RI. |
Rabbit anti-PB Cadherin Antibody |
|||
DL93887A-100ul | DL Develop | 100 ul | EUR 325 |
Description: C20orf25; Cadherin-22; Pituitary and brain cadherin; PB-cadherin |
Rabbit anti-PB Cadherin Antibody |
|||
DL93887A-50ul | DL Develop | 50 ul | EUR 227.5 |
Description: C20orf25; Cadherin-22; Pituitary and brain cadherin; PB-cadherin |
PB-cadherin (T134) polyclonal antibody |
|||
E43S2685 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
electrolyte galv.o2/pb electr., 125ml |
|||
B151 | Consort | ea | EUR 57.6 |
Pb(II) , DNA Aptamer, Biotinylated |
|||
AD-131-B | Alpha Diagnostics | Custom | Ask for price |
Pb(II) , DNA Aptamer, unlabeled |
|||
AD-131-U | Alpha Diagnostics | Custom | Ask for price |
Rabbit anti-PB Cadherin Antibody |
|||
YLD5967-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
Description: Rabbit polyclonal antibody to PB Cadherin |
Rabbit anti-PB Cadherin Antibody |
|||
YLD5967-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
Description: Rabbit polyclonal antibody to PB Cadherin |
Polymyxin-B PB 300 units |
|||
SD029-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Polymyxin-B PB 300 units |
Polymyxin-B PB 300 units |
|||
SD029-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Polymyxin-B PB 300 units |
Polymyxin-B PB 300 units |
|||
SD029-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Polymyxin-B PB 300 units |
Polymyxin-B PB 300 units |
|||
SD029-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Polymyxin-B PB 300 units |
Polymyxin-B PB 300 units |
|||
SD029-5X50DS | EWC Diagnostics | 1 unit | EUR 6.5 |
Description: Polymyxin-B PB 300 units |
Polymyxin-B PB 50 units |
|||
SD106-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Polymyxin-B PB 50 units |
Polymyxin-B PB 50 units |
|||
SD106-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Polymyxin-B PB 50 units |
Polymyxin-B PB 50 units |
|||
SD106-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Polymyxin-B PB 50 units |
Polymyxin-B PB 50 units |
|||
SD106-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Polymyxin-B PB 50 units |
Welcome to our blog!